Venous thromboembolism (VTE) risk stratification in general medical patients at an academic medical center

被引:9
作者
Fritz, Megan Kunka [1 ]
Kincaid, Scott E. [1 ]
Sargent, Charles G. [2 ]
Green, Amanda H. [3 ]
Davis, George A. [1 ]
机构
[1] Univ Kentucky HealthCare, Pharm Dept, 800 Rose St, Lexington, KY 40536 USA
[2] Univ Kentucky HealthCare, Div Hosp Med, 800 Rose St, Lexington, KY 40536 USA
[3] Univ Kentucky HealthCare, Dept Nursing, 800 Rose St, Lexington, KY 40536 USA
关键词
Venous thromboembolism; Classification; Risk factors; Low molecular weight heparin; Heparin; PROPHYLAXIS; PREVENTION; GUIDELINES; THROMBOSIS; MODEL;
D O I
10.1007/s11239-020-02144-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hospital-acquired venous thromboembolism (VTE) is still a concern for general medical patients. Pharmacologic prophylaxis can reduce VTE incidence, but there is the potential for adverse effects. Therefore, determining which patients should receive VTE prophylaxis via risk scoring tools is essential. Limited evidence exists for the ideal venous thromboembolism risk assessment model (RAM) in hospitalized medical patients, as compared to other hospitalized patient subgroups such as surgical patients. The primary objective was to investigate the utilization and appropriateness of our institution-based VTE RAM and comparison to the Padua Prediction Score (PPS). This would allow for a gauge of provider risk assessment accuracy as well as appropriate predictive potential of the PPS or whether an alternative to the PPS should be considered. A total of 330 adult general medicine patients were included in this retrospective chart review. When compared to our institution-based VTE RAM, providers predominately stratified patients at a higher VTE risk than the institution-based VTE RAM. VTE incidence was 0.3%, which was lower than predicted. Significant discordance exists between providers' VTE risk assessment and that predicted by RAMs. Our institution-based VTE RAM appears comparable to PPS; however, it was not being utilized by providers, resulting in potentially unnecessary use of pharmacologic prophylaxis. The most appropriate venous thromboembolism risk assessment model for general medicine patients is undetermined. Our providers generally assess patients as moderate or high VTE risk, despite our institution-based RAM which typically recommends a lower risk category than provider selection. Because of provider risk assessment, more patients received pharmacologic VTE prophylaxis than would have been recommended by the RAM, which might correlate to the low incidence of VTE which was < 0.5%, although bleeding complications were not assessed in this study. A prospective study utilizing the Padua Prediction Score (or similar RAM) in general medicine patients is warranted in order to decipher the best method of predicting VTE risk.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 26 条
[1]  
[Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1, DOI DOI 10.1109/IEEESTD.2010.5514475
[2]   A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score [J].
Barbar, S. ;
Noventa, F. ;
Rossetto, V. ;
Ferrari, A. ;
Brandolin, B. ;
Perlati, M. ;
De Bon, E. ;
Tormene, D. ;
Pagnan, A. ;
Prandoni, P. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (11) :2450-2457
[3]   Improving hospital venous thromboembolism prophylaxis with electronic decision support [J].
Bhalla, Rohit ;
Berger, Matthew A. ;
Reissman, Stan H. ;
Yongue, Brandon G. ;
Adelman, Jason S. ;
Jacobs, Laurie G. ;
Billett, Henny ;
Sinnett, Mark J. ;
Kalkut, Gary .
JOURNAL OF HOSPITAL MEDICINE, 2013, 8 (03) :115-120
[4]   External validation of the simplified Geneva risk assessment model for hospital-associated venous thromboembolism in the Padua cohort [J].
Blondon, Marc ;
Righini, Marc ;
Nendaz, Mathieu ;
Glauser, Frederic ;
Robert-Ebadi, Helia ;
Prandoni, Paolo ;
Barbar, Sofia .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (03) :676-680
[5]   Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study [J].
Cohen, Alexander T. ;
Tapson, Victor F. ;
Bergmann, Jean-Francois ;
Goldhaber, Samuel Z. ;
Kakkar, Ajay K. ;
Deslandes, Bruno ;
Huang, Wei ;
Zayaruzny, Maksim ;
Emery, Leigh ;
Anderson, Frederick A., Jr. .
LANCET, 2008, 371 (9610) :387-394
[6]   Guidelines-Based Use of Thromboprophylaxis [J].
Deitelzweig, Steven B. ;
Sasahara, Arthur ;
Michota, Franklin ;
McKean, Sylvia C. ;
Jacobson, Anne .
JOURNAL OF HOSPITAL MEDICINE, 2009, 4 (08) :S8-S15
[7]   Meta-analysis: Anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients [J].
Dentali, Francesco ;
Douketis, James D. ;
Gianni, Monica ;
Lim, Wendy ;
Crowther, Mark A. .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (04) :278-288
[8]   Hospital Performance for Pharmacologic Venous Thromboembolism Prophylaxis and Rate of Venous Thromboembolism A Cohort Study [J].
Flanders, Scott A. ;
Greene, M. Todd ;
Grant, Paul ;
Kaatz, Scott ;
Paje, David ;
Lee, Bobby ;
Barron, James ;
Chopra, Vineet ;
Share, David ;
Bernstein, Steven J. .
JAMA INTERNAL MEDICINE, 2014, 174 (10) :1577-1584
[9]   Prophylaxis for thromboembolism in hospitalized medical patients [J].
Francis, Charles W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (14) :1438-1444
[10]   Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S